Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir vs Nelfinavir in Antiretroviral-Naive HIV-Infected Patients
NCT00004583Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 1999
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Abbott Laboratories. Started Mar 1999; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00004583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004583.